Related Experiment Videos
White matter hyperintensity progression and late-life depression outcomes
Warren D Taylor1, David C Steffens, James R MacFall
1Department of Psychiatry, Duke University Medical Center, DUMC 3903, Durham, NC 27710, USA. Taylo066@mc.duke.edu
Archives of General Psychiatry
|November 12, 2003
Summary
Progression of white matter hyperintensities (WMH) in older adults with depression is linked to poorer treatment outcomes. Reduced WMH volume increase was observed in those who achieved sustained remission from depression.
Area of Science:
- Neuroimaging
- Geriatric Psychiatry
- Neurology
Background:
- White matter hyperintensities (WMHs) are visible on MRI and associated with geriatric depression.
- WMHs are expected to increase with age, but their progression in depression is understudied.
- This is the first longitudinal volumetric MRI study on WMHs in depression.
Purpose of the Study:
- To investigate the relationship between WMH progression over two years and depression outcomes in older adults.
- To determine if changes in WMH volume influence the likelihood of achieving and sustaining remission from depression.
Main Methods:
- A longitudinal study involving 133 participants aged 60+ with major depressive disorder.
- Antidepressant treatment was administered over two years following a naturalistic treatment algorithm.
- Cranial MRI was used at baseline and two years later to measure WMH volume using semiautomated segmentation.
Main Results:
- Participants achieving sustained depressive remission showed significantly less WMH volume increase (11.5%) compared to those who did not (31.6%).
- Increased WMH volume change was a significant predictor of failure to sustain remission, even after controlling for covariates.
- Higher education levels were associated with achieving and sustaining remission.
Conclusions:
- Greater progression of white matter hyperintensities is associated with adverse outcomes in geriatric depression.
- Further research is needed to explore interventions that slow WMH progression and their impact on depression outcomes in the elderly.